Skip to main content
Year archive

NEXALIS THERAPEUTICS LTD — 2022 filings

All 42 regulatory filings released by NEXALIS THERAPEUTICS LTD (NX1) in 2022, sourced directly from the official regulator.

42 Filings
2022 Period
2022 filings (42)
Filing Released Lang
Contract Research Organisation Appointment 2 pages 170.9KB
Regulatory Filings
2022-12-21 English
Change of Director's Interest Notice 3 pages 275.9KB
Director's Dealing
2022-12-15 English
Appendix 3G 18 pages 279.1KB
Capital/Financing Update
2022-12-14 English
Appendix 3G (Updated) 18 pages 288.6KB
Share Issue/Capital Change
2022-12-14 English
FDA Pre-IND Application Update 2 pages 174.6KB
Capital/Financing Update
2022-12-11 English
Change in substantial holding 2 pages 286.6KB
Major Shareholding Notification
2022-11-13 English
Quarterly Appendix 4C Cash Flow Report 5 pages 275.9KB
Interim / Quarterly Report
2022-10-30 English
Quarterly Activities Report 7 pages 444.6KB
Interim / Quarterly Report
2022-10-30 English
Change in substantial holding 2 pages 187.6KB
Major Shareholding Notification
2022-10-18 English
Section 708A Notice 1 page 150.7KB
Capital/Financing Update
2022-10-09 English
Final Director's Interest Notice 2 pages 260.1KB
Director's Dealing
2022-10-03 English
Initial Director's Interest Notice 2 pages 251.0KB
Director's Dealing
2022-10-03 English
Appendix 3B (updated) 54 pages 518.2KB
Capital/Financing Update
2022-10-02 English
Appendix 2A 20 pages 303.1KB
Capital/Financing Update
2022-10-02 English
Appendix 2A 20 pages 303.1KB
Share Issue/Capital Change
2022-10-02 English
Board and Management Changes 3 pages 127.4KB
Board/Management Information
2022-09-26 English
Update to Share Placement 1 page 147.4KB
Capital/Financing Update
2022-09-25 English
Appendix 3B (updated) 54 pages 635.9KB
Capital/Financing Update
2022-09-25 English
Appendix 3B (updated) 54 pages 637.1KB
Capital/Financing Update
2022-09-25 English
Private Placement to raise $1.2m 1 page 167.7KB
Capital/Financing Update
2022-09-18 English
Proposed issue of securities - IRX 5 pages 27.3KB
Capital/Financing Update
2022-09-18 English
Proposed issue of securities - IRX 5 pages 28.0KB
Capital/Financing Update
2022-09-18 English
Trading Halt 2 pages 204.9KB
Capital/Financing Update
2022-09-14 English
Half Yearly Report and Accounts 18 pages 1.6MB
Interim / Quarterly Report
2022-08-30 English
Quarterly Appendix 4C Cash Flow Report 5 pages 325.6KB
Interim / Quarterly Report
2022-07-27 English
Quarterly Activities Report 5 pages 706.3KB
Interim / Quarterly Report
2022-07-27 English
Ceasing to be a substantial holder 2 pages 748.8KB
Regulatory Filings
2022-07-03 English
Notification of cessation of securities - IRX 4 pages 24.1KB
Share Issue/Capital Change
2022-06-06 English
Constitution 48 pages 615.8KB
Governance Information
2022-06-05 English
Chairman's address 2 pages 194.0KB
AGM Information
2022-05-30 English
AGM Presentation 21 pages 1.6MB
Investor Presentation
2022-05-30 English
Results of Meeting 2 pages 174.8KB
Declaration of Voting Results & Voting Rights Announcements
2022-05-30 English
Quarterly Appendix 4C Cash Flow Report 5 pages 259.9KB
Interim / Quarterly Report
2022-04-28 English
Quarterly Activities Report 4 pages 447.1KB
Interim / Quarterly Report
2022-04-28 English
Notice of Annual General Meeting/Proxy Form 33 pages 497.7KB
AGM Information
2022-04-27 English
Annual General Meeting Letter to Shareholders 3 pages 232.2KB
AGM Information
2022-04-27 English
Annual Report to shareholders 46 pages 1.1MB
Annual Report
2022-03-30 English
Appendix 4G & Corporate Governance Statement 24 pages 525.9KB
Governance Information
2022-03-30 English
IRX granted wholesale licenses for scheduled substances 2 pages 174.7KB
Regulatory Filings
2022-03-29 English
Preliminary Final Report 13 pages 471.3KB
Interim / Quarterly Report
2022-02-27 English
Quarterly Appendix 4C Cash Flow Report 5 pages 228.4KB
Interim / Quarterly Report
2022-01-30 English
Quarterly Activities Report 4 pages 554.0KB
Interim / Quarterly Report
2022-01-30 English